Inserm Transfert Initiative logo

Inserm Transfert Initiative

Europe, Ile-de-France, France, Paris

Description

Inserm Transfert Initiative is a seed stage life science vehicle currently managing about €4.2M for the financing of new biotech

Investor Profile

Inserm Transfert Initiative has backed more than 19 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 5 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series Unknown, Series B rounds (top funding stages).
  • Majority of deals are located in France, Switzerland.
  • Strong thematic focus on Biotechnology, Health Care, Medical.

Stage Focus

  • Series A (37%)
  • Series Unknown (26%)
  • Series B (21%)
  • Seed (16%)

Country Focus

  • France (74%)
  • Switzerland (26%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Medical Device
  • 3d Printing
  • Biopharma
  • Pharmaceutical
  • Genetics
  • Information Technology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Inserm Transfert Initiative frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 6
I
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Versant Ventures
North America, California, United States, Menlo Park
Co-Investments: 6
CH
North America, New York, United States, New York
Co-Investments: 3
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 3
Tekla Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 3
Idinvest Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 2
Bpifrance
Europe, Ile-de-France, France, Maisons-alfort
Co-Investments: 8
Pontifax
Asia, Tel Aviv, Israel, Herzliya
Co-Investments: 2
Karista
Europe, Ile-de-France, France, Paris
Co-Investments: 2

What are some of recent deals done by Inserm Transfert Initiative?

Step Pharma

Paris, Ile-de-France, France

Step Pharma is a biotechnology company.

BiotechnologyPharmaceutical
Series COct 15, 2025
Amount Raised: $44,177,262
VectivBio

Basel, Basel-Stadt, Switzerland

VectivBio is a biotechnology company committed to making innovative treatments for patients suffering from serious rare diseases.

BiotechnologyHealth CareMedical
Series UnknownOct 19, 2020
Amount Raised: $110,000,000
Eyevensys

Paris, Ile-de-France, France

Eyevensys creates ophthalmic therapeutic bio factories to sustainably treat major eye diseases.

BiotechnologyMedical DeviceTherapeutics
Series BJan 8, 2020
Amount Raised: $30,000,000
VectivBio

Basel, Basel-Stadt, Switzerland

VectivBio is a biotechnology company committed to making innovative treatments for patients suffering from serious rare diseases.

BiotechnologyHealth CareMedical
Series AJan 8, 2020
Amount Raised: $35,000,000
Aelis Farma

Bordeaux, Aquitaine, France

Aelis Farma is a biotech company conducting research and development on innovative signaling specific drugs

BiotechnologyTherapeutics
Series UnknownDec 13, 2019
Amount Raised: $12,232,552
Therachon

Basel, Basel-Stadt, Switzerland

Therachon is a global biotechnology company focused on developing medicines for rare, genetic diseases

BiotechnologyMedicalTherapeutics
Series BAug 9, 2018
Amount Raised: $60,000,000
BIOMODEX

Paris, Ile-de-France, France

BIOMODEX is a medical technology company using 3D printing to create tissue-like anatomical twins for rehearsal of surgeries.

3D PrintingHealth CareMedical Device
Series AJun 8, 2018
Amount Raised: $15,000,000
ENYO Pharma

Lyon, Rhone-Alpes, France

ENYO Pharma is a biopharmaceutical company based in Lyon, France.

BiopharmaBiotechnologyMedical
Series BJun 4, 2018
Amount Raised: $46,800,485
Step Pharma

Paris, Ile-de-France, France

Step Pharma is a biotechnology company.

BiotechnologyPharmaceutical
Series ANov 21, 2017
Amount Raised: $17,025,614
Therachon

Basel, Basel-Stadt, Switzerland

Therachon is a global biotechnology company focused on developing medicines for rare, genetic diseases

BiotechnologyMedicalTherapeutics
Series AJan 6, 2017
Amount Raised: $5,000,000

Find More Investors Like Inserm Transfert Initiative

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Inserm Transfert Initiative | Pipeseed